Recent Articles

The Cancer Moonshot Summit: Reaching New Heights

| June 30, 2016 | 0 Comments

The Cancer Moonshot Summit: Reaching New Heights Yesterday, I attended the Cancer Moonshot Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, held at Howard University in Washington, DC. In addition to this Summit, there were more than 250 regional summits happening simultaneously, making this truly a national event.The summits were an opportunity […]

Continue Reading

Prognosis Discussions Improve Understanding of Illness for Patients with Terminal Cancer

| June 27, 2016 | 0 Comments

Prognosis Discussions Improve Understanding of Illness for Patients with Terminal Cancer New study results show that many patients with advanced, incurable cancer have a poor understanding of their prognosis or life expectancy. Fewer than one in four patients in the study reported having a recent discussion about prognosis with their oncologist, although those who did […]

Continue Reading

New on NCI’s Websites for June 2016

| June 16, 2016 | 0 Comments

New on NCI’s Websites for June 2016 NCI constantly publishes new information on its websites, so periodically we provide updates on new content of interest to the cancer community. See Original Article

Continue Reading

CURE Spotlight: Cesar Castro, M.D. Develops Smartphone Technology for Cancer Detection in Underserved Communities

| June 15, 2016 | 0 Comments

CURE Spotlight: Cesar Castro, M.D. Develops Smartphone Technology for Cancer Detection in Underserved Communities Cesar Castro, M.D., a former K12 CURE scholar and now Director of the Cancer Program at Massachusetts General Hospital Center for Systems Biology, and a team of researchers have developed a smartphone-based technology that converts a smartphone into a tool for […]

Continue Reading

Grantee Spotlight: Marvella Ford, Ph.D. – Reducing Barriers to Surgical Cancer Care among African Americans with Lung Cancer

| June 15, 2016 | 0 Comments

Grantee Spotlight: Marvella Ford, Ph.D. – Reducing Barriers to Surgical Cancer Care among African Americans with Lung Cancer Two investigators at the National Cancer Institute (NCI)-designated Medical University of South Carolina (MUSC) Hollings Cancer Center—Marvella E. Ford (Ph.D.) and Nestor F. Esnaola (M.D., M.P.H., M.B.A.), were awarded a five-year National Institutes of Health (NIH)/National Institute […]

Continue Reading

Targeting RAL-GEF signaling and cytokines in KRAS driven lung cancer

| June 14, 2016 | 0 Comments

Targeting RAL-GEF signaling and cytokines in KRAS driven lung cancer Given the challenges associated with targeting KRAS directly, much recent attention has been directed at inhibiting one or more of its multiple downstream signaling pathways. Indeed, small molecules that target kinases along the PI3K-AKT and RAF-MEK-ERK axes have been tested in clinical trials in various […]

Continue Reading

Genome Study Yields Clues to Head and Neck Cancers

| June 14, 2016 | 0 Comments

Genome Study Yields Clues to Head and Neck Cancers Researchers have surveyed the genetic changes in nearly 300 head and neck cancers, revealing some previously unknown alterations that may play a role in the disease, including in patients whose cancer is associated with the human papillomavirus (HPV). HPV is the most common sexually transmitted virus […]

Continue Reading

Cancer Can Lead to Financial Hardship, Study Confirms

| June 14, 2016 | 0 Comments

Cancer Can Lead to Financial Hardship, Study Confirms In a survey of cancer survivors, many reported having experienced financial difficulties—such as going into debt, filing for bankruptcy, and consistent worry about financial issues—related to their disease and its treatment.The findings from the study were published November 7 in the Journal of Clinical Oncology. See Original […]

Continue Reading

Cancer Risk in Childhood Cancer Survivors Continues for Decades

| June 13, 2016 | 0 Comments

Cancer Risk in Childhood Cancer Survivors Continues for Decades Survivors of childhood cancer have an elevated risk of developing second, distinct cancers into their forties and beyond, according to a new study.Several studies have documented childhood cancer survivors’ increased risk of developing a second cancer, but this new study is among the first to assess […]

Continue Reading

FDA Approves First Immunotherapy Treatment for Lung Cancer

| June 13, 2016 | 0 Comments

FDA Approves First Immunotherapy Treatment for Lung Cancer On March 4, the U.S. Food and Drug Administration approved nivolumab (Opdivo) to treat patients with advanced non-small cell lung cancer (NSCLC) that has progressed during or after treatment with platinum-based chemotherapy.Nivolumab, which was initially approved for the treatment of metastatic melanoma, is the first immunotherapy drug […]

Continue Reading